<MedlineCitation Status="Completed">
<MedlineID>10011552</MedlineID>
<PMID>33730</PMID>
<DateCreated>
<Year>1979</Year>
<Month>05</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted>
<Year>1979</Year>
<Month>05</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised>
<Year>2000</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article>
<Journal>
<ISSN>0006-3223</ISSN>
<JournalIssue>
<Volume>14</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1979</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
</Journal>
<ArticleTitle>Hoffmann reflex abnormalities in psychotic patients.</ArticleTitle>
<Pagination>
<MedlinePgn>95-110</MedlinePgn>
</Pagination>
<AuthorList>
<Author>
<LastName>Goode</LastName>
<ForeName>D J</ForeName>
<Initials>DJ</Initials>
</Author>
<Author>
<LastName>Meltzer</LastName>
<ForeName>H Y</ForeName>
<Initials>HY</Initials>
</Author>
<Author>
<LastName>Mazura</LastName>
<ForeName>T A</ForeName>
<Initials>TA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>UNITED STATES</Country>
<MedlineTA>Biol Psychiatry</MedlineTA>
<NlmUniqueID>0213264</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Antipsychotic Agents, Phenothiazine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>50-53-3</RegistryNumber>
<NameOfSubstance>Chlorpromazine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>51-64-9</RegistryNumber>
<NameOfSubstance>Dextroamphetamine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>7439-93-2</RegistryNumber>
<NameOfSubstance>Lithium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName>Acute Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Antipsychotic Agents, Phenothiazine</DescriptorName>
<QualifierName>therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Bipolar Disorder</DescriptorName>
<QualifierName>drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y">physiopathology</QualifierName>
<QualifierName>psychology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Chlorpromazine</DescriptorName>
<QualifierName>therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Dextroamphetamine</DescriptorName>
<QualifierName>pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Electric Stimulation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">H-Reflex</DescriptorName>
<QualifierName>drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Human</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Lithium</DescriptorName>
<QualifierName>therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Reflex, Abnormal</DescriptorName>
<QualifierName MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y">Reflex, Monosynaptic</DescriptorName>
<QualifierName>drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Refractory Period, Neurologic</DescriptorName>
<QualifierName>drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Schizophrenia</DescriptorName>
<QualifierName>drug therapy</QualifierName>
<QualifierName MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Schizophrenic Psychology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName>Tibial Nerve</DescriptorName>
<QualifierName>physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
